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Abstract: Background: The aim of the study was to compare the oral-health-related quality of life
(OHRQoL) between cancer survivors: with rapid orthodontic treatment (TX) (up to 12 months) and 
standard TX (orthodontic treatment time longer than 16 months). Methods: There were 76 cancer 
survivors (48 women and 28 men) allocated into groups with rapid (36 people) or standard (40 people) 
duration of TX. OHRQoL was assessed on the basis of Oral Health Impact Profile (OHIP-14) values, 
measured before TX, 2 weeks and 3 months after the onset of TX, and after the end of TX. A repeated 
ANOVA test was used to check the statistical significance between the scores. Results: There were no 
significant differences regarding the OHIP-14 values between the examined groups at all stages of the 
examination. Both groups presented significant (p <  0.001) improvement of the values of OHRQoL at 
the end of TX comparing to the values achieved before the onset of TX. Conclusions: Duration of 
orthodontic treatment by itself had no impact on oral-health-related quality of life.
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1. Introduction
"Cancer survivor" is a general term describing an adolescent or adult patient who was diagnosed 
with cancer and successfully underwent oncological treatment. Although the exact number of 
children diagnosed with cancer each year is unknown, the statistics present the increase in the 
incidence rates of cancers among children [1,2]. Children are most often diagnosed with leukemias,
lymphomas, and tumors of central nervous system [1,2]. The cancer treatment modalities encompass 
chemotherapy, radiotherapy, surgery, and a combination of the above-mentioned methods [3]. 
Because of better understanding of the cancer biology and thanks to the advances in oncological 
treatment, the 5-year survival rates have been improved. Nowadays, the 5-year survival rates 
have achieved the value of 80% [4,5]. The European country-weighted 5-year survival assessed 
for patients diagnosed with cancer from 2000 to 2007 presented as follows: acute lymphoid 
leukemia—86.3%, acute myeloid leukemia—62.7%, Hodgkin's lymphoma—95.4%, non-Hodgkin 
lymphoma (except Burkitt's lymphoma)—84.0%, Burkitt's lymphoma—90.2%, Central Nervous 
System (CNS) and miscellaneous intercranial and intraspinal neoplasms—57.5%, neuroblastoma
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and ganglioneuroblastoma—70.6%, retinoblastoma—96.4%, nephroblastoma and other nonepithelial 
renal tumors—89.4%, osteosarcomas—69.3%, Ewing's sarcoma and related sarcomas of bone—67.9%, 
rhabdomyosarcomas—67.7% [4]. Therefore, the number of cancer survivors is continuously increasing. 
According to the literature, one out of 900 young adults received successful oncological treatment in 
their childhood [6]. As a consequence, there is also an increase in the number of cancer survivors 
seeking orthodontic treatment.
It was assessed that 72% of orthodontists who had treated cancer survivors reported the presence 
of some dental complications that occurred as consequences of oncological treatment. These dental 
complications included the following: malaligned teeth (22%), root stunting (17%), growth and 
development changes (16%), missing teeth (13%), delay in loss of deciduous teeth (12%), microdontia 
(11%), and enamel hypoplasia (9%) [7,8]. Moreover, irradiation in the area of the head and neck may 
lead to oral mucositis, dysfunctional taste, and malnutrition as well as radiation caries [9]. Because 
of this fact, that most of the cancer survivors presented some dental complications, and the majority 
of orthodontists (75%) prescribed some modifications to orthodontic treatment [7]. The American 
Academy of Pediatric Dentistry (AAPD) recommended five different strategies for the orthodontic 
treatment of cancer survivors, including the following: usage of the appliances that reduce the risk of 
root resorption, usage of lighter forces, choosing the simplest method for the treatment needs, not to 
treat the lower arch, and finally to terminate the treatment earlier than normal [10].
Estimated orthodontic treatment time is one of the most important pieces of information for the 
patients. Patients, who finish their treatment on time, seem to be more satisfied [11]. There are many 
factors that affect estimated treatment time [11]. One of these, that should be considered, is previous 
oncological treatment. Cancer survivors may need rapid orthodontic treatment because of the planned 
oncological follow-up or maintenance therapy. Moreover, their orthodontic treatment sometimes has 
to be suspended for a while.
One of the major goals of orthodontic treatment in cancer survivors is the improvement of patients' 
quality of life. The quality of life is a complex term encompassing individuals' perception of different 
aspects of life. The World Health Organization defined quality of life as an "individual's perception 
of their position in life in the context of the culture and value systems in which they live and in 
relation to their goals, expectations, standards and concerns. It is a broad ranging concept affected in a 
complex way by the person's physical health, psychological state, personal beliefs, social relationships 
and their relationship to salient features of their environment" [12,13]. Oral-health-related quality 
of life (OHRQoL) measures how oral diseases or conditions related to the oral cavity influence the 
patient's life [14]. It has been proven that malocclusions leading to severely compromised esthetics 
have negative impact on OHRQoL [15], which improves after the end of orthodontic treatment [16]. 
However, the initial phases of orthodontic treatment have been found to have a negative impact on 
OHRQoL [17]. Unfortunately, little is known about the influence of orthodontic treatment on OHRQoL 
in the group of cancer survivors [18].
Therefore, the aim of the study was to compare prospectively the oral-health-related quality of life 
between two groups of cancer survivors: those who had undergone rapid orthodontic treatment (up to 
12 months) and standard orthodontic treatment (orthodontic treatment time longer than 16 months) 
from 2012 till 2016 in Krakow (Poland).
2. Materials and Methods
The Medical Board Ethical Committee (50/KBL/OIL/2010) approved the study. This research 
was conducted with the ethical principles of the World Medical Association Declaration of Helsinki.
Informed consent was received and signed by all the patients. Parents received a letter describing the 
study protocol and requesting consent for their children to participate in the study.
2.1. Study Population
The patients from both groups were selected and treated in the same specialist orthodontic private 
practice in Krakow (Poland). There were 81 participants (50 women and 31 men; median age: 19.3; 
age range: 13-28 years) enrolled into the study. All the patients had successfully undergone oncological 
treatment in their childhood due to cancer and came to the specialist orthodontic practice looking 
for orthodontic treatment. The exclusion criteria were as follows: previous orthodontic treatment, 
severe dentofacial anomalies, poor periodontal health, and patients who did not agree to take part into 
the study.
Before the onset of orthodontic treatment, each patient was referred for a specialist oncological 
consultation. Having received the relevant information from the oncologists, patients were allocated 
into two groups with rapid and standard duration of orthodontic treatment. Patients with the risk of 
possible hospitalization, magnetic resonance imaging examination, or any other types of oncological 
examinations that could have influenced orthodontic treatment within the following one year, were 
classified to the rapid orthodontic group. The orthodontic treatment in the rapid group was expected 
to be completed within the next 12 months. The remaining patients were classified as the control group 
or the group with standard duration of orthodontic treatment. The control group was not limited by 
the duration of the orthodontic treatment.
The flow chart of participation is presented in Figure 1. Table 1 presents the general characteristics 
of the cancer survivors and the control groups.
Figure 1. The flow chart of participation diagram.
Table 1. General characteristics of cancer survivors and control group of patients.
Factor Rapid Group Standard Group p-Value a
Number of patients (n) 
(female/male ratio) 





Skeletal class 1 :10 
Skeletal class II: 20 
Skeletal class III: 6
40 (22/18)
19.2 (14-28) 
Skeletal class I: 14 
Skeletal class II: 22 




1 U Mann-Whitney test.
Table 2 presents the general characteristics of both rapid and standard groups with reference to 
the diagnosed type of cancer, including mean age at diagnosis, follow-up time, and treatment modality.
Table 2. General characteristics of both rapid and standard groups with reference to the diagnosed 
type of cancer, including mean age at diagnosis, follow-up time, and treatment modality.
D iagnosis N um ber of 
Cases




Treatm ent M odality  
Chem otherapy Radiotherapy
Rapid Group 36
Leukemia 22 3.9 ±  1.5 8.8 ±  4.2 22 0
Neuroblastoma 3 0.8 ±  0.5 4.1 ±  1.2 3 0
Soft tissue sarcoma 2 2.5 ±  1.1 6.4 ±  2.4 2 1
Non-Hodgkin's lymphoma 6 4.9 ±  2.4 7.3 ±  3.3 6 1
Wilms' tumor 3 3.2 ±  2.2 6.8 ±  3.1 3 0
Standard Group 40
Leukemia 25 3.2 ±  1.2 9.8 ±  3.7 25 0
Neuroblastoma 4 0.8 ±  0.5 5.4 ±  1.2 4 0
Soft tissue sarcoma 3 2.2 ±  0.8 7.5 ±  2.2 3 1
Non-Hodgkin's lymphoma 2 4.6 ±  2.4 7.6 ±  3.9 2 1
Wilms' tumor 6 3.6 ±  2.3 6.6 ±  2.9 6 0
2.2. Study Protocol
This was a prospective case-control study. The patients from both groups (with rapid and standard 
duration of orthodontic treatment) were selected and treated in the same specialist orthodontic private 
practice in Krakow (Southern Poland). The process of standard orthodontic diagnosis was based 
on extraoral and intraoral orthodontic examination, analysis of extraoral and intraoral photographs, 
plaster casts analysis, lateral cephalogram analysis, and dental panoramic tomogram analysis. All the 
records were collected prospectively. The orthodontic diagnosis and qualification to orthodontic 
treatment were performed by two independent certified specialists of orthodontics [18].
The orthodontic treatments of all participants were performed with vestibular fixed orthodontic 
appliances both in the maxilla, as well as in the mandible. We used traditional, ceramic, twin brackets 
with a 0.022 inch bracket slot and with MBT (McLaughlin/Bennett/Trevisi) prescription. Sliding mechanics 
was used in both groups. There was no need for the usage of skeletal anchorage devices. Intermaxillary 
elastics and the Goshgarian transpalatal bar were enough to gain satisfactory anchorage.
The goals of the orthodontic treatment were to achieve ideal occlusion as defined by 
Andrews [19], well-balanced facial profile, and to avoid complications that could have occurred 
in post-oncological-treatment patients. The primary endpoint of the study was to assess the influence of 
orthodontic treatment on patients' health-related quality of life regarding the duration of the treatment.
The oral-health-related quality of life was assessed on the basis of the 14-item Oral Health 
Impact Profile (OHIP-14) Questionnaire [16,20]. The OHIP-14 Questionnaire was translated into 
the Polish language, following the principles recommended by the World Health Organization 
(forward translation, expert panel back-translation, pre-testing and cognitive interviewing, and final 
version) [21]. The OHIP-14 Questionnaire consists of 7 domains, namely, functional limitation, 
physical pain, psychological discomfort, physical disability, psychological disability, social disability, 
and handicap. There are two questions in each domain. The five-point Likert scale was used for 
rating patients' responses. The answers were coded with the numbers: 0 (=never), 1 (=hardly ever), 
2 (=occasionally), 3 (=fairly often), and 4 (=very often/every day) [22]. To score the answers marked 
by the patients, we used two different methods: the OHIP-14 additive method and the OHIP-14 simple 
count method. In the OHIP-14 additive method, the total score was achieved by summing the ordinal 
values for the 14 above-mentioned questions (the minimum score was 0 and the maximum score was 
56). In the OHIP-14 simple count method, the final result was calculated by summing up the number 
of domains reported as occasionally or more frequently (therefore the total score ranged from 0 to 7). 
The OHIP-14 Questionnaires were filled in by the patients several times: before orthodontic treatment, 
2 weeks after the onset of orthodontic treatment, 3 months after the onset of orthodontic treatment, 
and finally in the retention period. Table 3 presents the OHIP-14 Questionnaire. Pre-treatment values 
of the OHIP-14 were used as control ones.
Table 3. The 14-item Oral Health Impact Profile (OHIP-14) Questionnaire [18,20].
The List of Questions in the OHIP-14 Questionnaire
Functional Limitation
1. Have you had trouble pronouncing any words because of problems with your teeth or mouth?
2. Have you felt that your sense of taste has worsened because of problems with your teeth or mouth?
Physical Pain
3. Have you had painful aching in your mouth?
4. Have you found it uncomfortable to eat any foods because of problems with your teeth or mouth?
Psychological Discomfort
5. Have you been self-conscious because of your teeth or mouth?
6. Have you felt tense because of problems with your teeth or mouth?
Physical Disability
7. Has been your diet been unsatisfactory because of problems with your teeth of mouth?
8. Have you had to interrupt meals because of problems with your teeth or mouth?
Psychological Disability
9. Have you found it difficult to relax because of problems with your teeth or mouth?
10. Have you been a bit embarrassed because of problems with your teeth or mouth?
Social Disability
11. Have you been a bit irritable with other people because of problems with your teeth or mouth?
12. Have you had difficulty doing your usual jobs because of problems with your teeth or mouth?
Handicap
13. Have you felt that life in general was less satisfying because of problems with your teeth or mouth?
14. Have you been totally unable to function because of problems with your teeth or mouth?
2.3. Statistical Analysis
The data were analyzed using Statistica 13.0 software (Dell Inc., Aliso Viejo, CA, USA). No data 
were missing. Categorical variables were described as percentages of the total population, while 
continuous variables were reported as median and range. The Pearson's chi-square or Fisher's exact 
test was used to compare categorical variables. The Shapiro-Wilk and the Kolmogorov-Smirnov tests, 
with the Lilliefors correction, were used to confirm the normality of the distribution of the continuous 
variables. Finally, the unpaired Student t test or the nonparametric Mann-Whitney U test was used for 
comparisons. The ANOVA with repeated responses was used to assess differences in OHIP-14 across 
groups and time of treatment. Statistical significance was set at p < 0.05.
3. Results
We calculated the required sample size considering the results of a pilot group, 90% of power 
and type I error of 0.05. To detect 20% difference between the groups in the OHIP-14 index after the 
treatment, the study sample in each group should include at least 34 patients.
Finally, there were 76 participants (48 women and 28 men; median age: 19.4, age range: 13-28 years) 
included in the study, because of the fact that one patient was excluded due to poor oral hygiene and 
four patients were lost during follow-up. There were 24 patients with skeletal class I malocclusion, 
42 patients with skeletal class II malocclusion, and 10 patients with skeletal class III malocclusion 
(Table 1).
The vast majority of the patients in both groups had been diagnosed with leukemia (66.67% in 
rapid group vs. 55.0% in standard group). The frequency of other types of diagnosed cancers presented 
as follows: neuroblastoma (11.11% in rapid group vs. 7.50% in standard group), soft tissue sarcoma 
(2.78% in rapid group vs. 7.50% in standard group), non-Hodgkin's lymphoma (19.44% in rapid group 
vs. 15.0% in standard group). Patients diagnosed with Wilms' tumor were treated orthodontically only 
in the standard group (15.0%) (Table 2).
All of the patients had been treated in their childhood with chemotherapy. There were four 
patients who had received additional radiotherapy (two patients in each group), but none of them 
developed osteoradionecrosis. However, one of the patients needed hyperbaric oxygen support after 
the tooth extraction (Table 2).
Having analyzed dental panoramic tomograms, root resorption was diagnosed in four patients 
from the standard group. None of the patients from the rapid group presented any signs of root 
resorption. In all, 13 patients in the whole study suffered from oral mucositis (seven patients in 
the standard group vs. six patients in the rapid group). Moreover, 14 patients had their appliances 
temporarily removed to perform magnetic resonance imaging examinations (five patients in the rapid 
group vs. nine patients in the standard group).
The mean orthodontic treatment time was significantly shorter (p <  0.01) in the rapid group 
(11.3 months) comparing to that in the standard group (19.3 months). The mean follow-up time was 
similar in both groups and lasted 24.6 months.
The final results of orthodontic treatment, assessed on the basis of plaster casts, cephalometric 
images, and photographic documentation, presented no differences between the examined groups. 
However, there were four patients in the rapid group and two patients in the standard group who did 
not achieve the ideal occlusion at the end of orthodontic treatment.
3.1. OHIP-14 Mean Total Score
The OHIP-14 Mean Total Score values changed significantly throughout the orthodontic treatment 
in both groups. Two weeks and 3 months after the onset of orthodontic treatment, the OHIP-14 
Mean Total Score values were significantly higher (p < 0.001) comparing to the values obtained before 
the orthodontic treatment, both in the rapid and the standard groups. However, after the end of 
orthodontic treatment, the OHIP-14 Mean Total Score values were significantly lower (p <  0.001) in 
both groups comparing to the values obtained before the onset of orthodontic treatment. Although the 
values of the OHIP-14 Mean Total Score differed between the examined groups, the differences were 
statistically insignificant.
Table 4 presents the OHIP-14 Mean Total Score in the cancer survivors treated orthodontically 
according to the rapid and standard protocols, before, during, and after the orthodontic treatment.
Table 4. The OHIP-14 Mean Total Score in the cancer survivors treated orthodontically according to the
rapid and standard protocols before, during, and after orthodontic treatment.
Time of Orthodontic Treatment 
(TX)
Rapid Group 
(Mean ±  SD) 
(Range)
Standard Group 
(Mean ±  SD) 
(Range)
p-Value a
Before TX 4.1 ±  4.2 1'2'3 3.8 ±  3.0 4'5'6 0.311
2 weeks after the onset of TX
(0-14)
9.8 ±  8.2 1'7'8
(0-9)
10.2 ±  6.8 4'10'11 0.189
3 months after the onset of TX
(0-32)
7.8 ±  7.5 2'7'9
(0-20)
8.5 ±  4.3 5'10'12 0.324
After TX
(0-28)
1.1 ±  2.8 3'8'9
(0-15)
1.3 ±  2.3 6,11,12
0.108(0-14) (0-12)
1 12 Statistically significant differences with p <  0.001 (ANOVA), a Mann-Whitney U test, SD—standard deviation.
Having analyzed individual domains of the OHIP-14 score (functional limitation, physical pain, 
psychological discomfort, physical disability, psychological disability, social disability, and handicap), 
there were no statistically significant differences (p >  0.05) between the examined groups at all stages of 
the examination: before, during, and after the end of orthodontic treatment. Table 5 presents the mean 
OHIP-14 scores for individual domains observed before, during, and after orthodontic treatment for 
the two groups of cancer survivors: with the rapid and the standard duration orthodontic treatment.
3.2. OHIP-14 Simple Count
There were no statistically significant differences between the examined groups regarding the 
number of patients with impaired domains. Table 6 presents the number of patients with impaired
domains in cancer survivors with rapid and standard duration of orthodontic treatment.
Table 5. The mean OHIP-14 score for individual domains observed before, during, and after orthodontic treatment for the two groups of cancer survivors: with rapid 















Before 0.3 ± 0.6 0.1 ± 0.4 0.4 ± 0.7 0.7 ± 1.1 0.7 ± 1.2 0.4 ± 0.5 0.8 ± 1.3
(rapid vs. standard) 0.3 ± 0.5 0.1 ± 0.2 0.2 ± 0.5 0.6 ± 0.7 0.8 ± 1.1 0.3 ± 0.6 0.5 ± 1.2
2 weeks 0.8 ± 0.8 2.1 ± 2.5 1.3 ± 1.9 1.6 ± 1.4 1.2 ± 1.4 0.4 ± 0.7 0.7 ± 1.2
(rapid vs. standard) 0.9 ± 1.3 1.8 ± 2.1 1.1 ± 0.5 1.4 ± 1.1 1.0 ± 1.2 0.4 ± 0.5 0.6 ± 1.4
3 months 0.3 ± 0.8 1.3 ± 2.3 1.0 ± 1.5 1.4 ± 1.7 1.0 ± 1.3 0.4 ± 0.5 0.4 ± 1.2
(rapid vs. standard) 0.5 ± 0.8 1.1 ± 0.8 0.9 ± 1.3 1.2 ± 1.1 1.2 ± 0.9 0.2 ± 0.5 0.5 ± 1.8
After 0.1 ± 0.4 0.2 ± 0.5 0.2 ± 0.6 0.3 ± 0.6 0.1 ± 0.5 0.1 ± 0.4 0.1 ± 0.2
(rapid vs. standard) 0.1 ± 1.1 0.1 ± 0.3 0.1 ± 0.5 0.2 ± 0.4 0.1 ± 0.4 0.2 ± 0.3 0.1 ± 0.6















Before 2 0 6 8 8 7 8
(rapid vs. standard) 3 0 4 6 6 6 7
2 weeks 4 11 18 12 13 5 6
(rapid vs. standard) 4 12 16 11 11 4 5
3 months 7 10 7 9 9 5 5
(rapid vs. standard) 7 8 8 8 7 3 3
After 1 0 2 2 1 1 1
(rapid vs. standard) 0 1 1 1 1 1 0
The number of patients with oral health impacts reported as occasionally or more frequently on the 
basis of OHIP-14 Simple Count did not differ significantly between the two examined groups. Table 7 
presents the number and percentages of patients with oral health impacts reported as occasionally or 
more frequently, assessed on the basis of the OHIP-14 Simple Count.
Table 7. OHIP-14 Simple Count—the number of patients with oral health impacts reported as 
occasionally or more frequently.
Time of Orthodontic 
Treatment (TX) Rapid Group Standard Group p-Value a
Before 3 (8.3%) 3 (7.5%) 0.965
2 weeks 17 (47.2%) 18 (45.0%) 0.312
3 months 12 (33.3%) 12 (30.0%) 0.845
After the treatment 2 (5.6%) 1 (2.5%) 0.514
a Chi-square test.
4. Discussion
Assessment of the oral-health-related quality of life (OHRQoL) with reference to orthodontic 
treatment has been discussed by many authors [15- 18]. Although there are many different methods 
to measure OHRQoL, one of the most commonly used is the Oral Health Impact Profile (OHIP). 
The 14-question, shorter version of the OHIP survey presents good reliability and validity [16]. 
Therefore, we decided to use the OHIP-14 survey to assess OHRQoL among all of the patients included 
in the study. Our study was the first one that prospectively compared OHRQoL between two groups 
of cancer survivors: those who had undergone rapid orthodontic treatment (up to 12 months) and 
standard orthodontic treatment (orthodontic treatment time longer than 16 months).
There have been described several skeletal and dental complications, as well as complications 
related to oral mucous membrane in patients who had undergone oncological treatment in 
their childhood [23- 27]. The above-mentioned complications included hypodontia, microdontia, 
root malformation, enamel defects, growth and developmental changes, as well as oral mucositis [23- 27]. 
Sonis et al. [26] found that 94% of cancer survivors diagnosed with cancer below the age of 5 years 
old presented disturbed dental development. Moreover, children who had undergone oncological 
treatment below the age of 5 years old and those who had received radiotherapy, presented even more 
severe dental abnormalities. Kilinę et al. [25] presented similar observations. The authors classified the 
patients who had received oncological treatment below the age of 7 years old as a high-risk group 
for dental abnormalities. Furthermore, they also noticed that the incidence rates of microdontia and 
hypodontia increased when the patients had been treated oncologically below the age of 5 years old. 
Although, in our study, the mean age at oncological diagnosis was below 5 years old for each type of 
cancer in both groups, we did not observe any other dental abnormalities apart from root resorption. 
There were only four patients diagnosed with root resorption in the group with standard duration 
of orthodontic treatment. None of the patients from the rapid group presented any signs of root 
resorption. All our patients had been treated with chemotherapy, and four patients had received 
additional radiotherapy (two patients in each group). None of the chemoradiotherapy patients had 
received radiotherapy in the area of the head and neck, which could have explained why those patients 
had not developed the dental abnormalities described by other authors.
Disturbances in the growth of the craniofacial skeleton as consequences of oncologic treatment 
were also discussed in the literature [8,23,26]. Changes in skeletal growth were associated most 
often with radiotherapy. Sonis et al. [26] noticed that patients who had received chemotherapy with 
additional 2400 cGy radiotherapy in the area of head below the age of 5 years old, presented significantly 
deficient mandibular growth. Roman et al. [27] found that chemotherapy as a sole method of oncologic 
treatment in children interfered with growth, both during and after treatment. The authors noticed 
that chemotherapy provokes growth hormone deficiency. Although, the exact impact of chemotherapy
alone on mandibular growth has not been assessed yet, it may be speculated that if the chemotherapy 
alone provokes growth hormone deficiency, it could also lead to mandibular growth deficiency. 
The majority of cancer survivors included into our study had skeletal class II with deficient mandibular 
growth: 55.6% in rapid group and 55.0% in standard group. However, in our opinion, skeletal class 
II in those patients cannot be considered as a direct consequence of chemotherapy alone, because of 
two facts. Firstly, skeletal class II is a very common type of malocclusion in Poland, and secondly, 
there were also cancer survivors included in the study who were diagnosed with moderate skeletal 
class III with excessive mandibular growth and skeletal class I with optimal anteroposterior position of 
the maxilla and mandible.
Oral mucositis has been described as the acute reaction in the area of the oral cavity mucous 
membrane, which occurs during chemoradiotherapy. Its incidence seems to be underreported by 
oncologists [28,29]. There are five stages of mucositis progression: initiation, the primary damage 
response, amplification, ulceration, and healing. The initiation phase is characterized not only by direct 
DNA damage but also by the generation of reactive oxygen species [28]. Pain associated with oral 
mucositis was found to impair the function of the oral cavity: phonation, deglutition, and dysgeusia [29]. 
Finally, it was found that oral mucositis significantly diminished OHRQoL in patients diagnosed with 
cancer [29]. We have found that seven patients (17.5%) in the standard group and six patients (16.7%) 
in the rapid suffered from oral mucositis. There were no significant differences between the examined 
groups regarding the incidence of oral mucositis.
Apart from the abovementioned complications, one of our patients needed hyperbaric oxygen 
support after the extraction of the lower left third molar. According to the literature [30], complications 
post extractions in cancer patients ranged from 3% to 40%, and they occurred most commonly after 
third molar extraction, which stays in agreement with our observation. Although, the weighted 
prevalence of dental infections during cancer therapy is rather low (5.4%), use of fluoride and use of 
chlorhexidine are recommended, especially after radiotherapy in the area of head and neck [30].
Quality of life among children and adolescents with cancer was found to be associated with several 
variables, including general fatigue, sleep fatigue, cognitive fatigue, self-concern distress, physical and 
psychological distress, school life distress, relationship distress, family life distress, age at diagnosis, 
time since diagnosis, and family structure. Four major predictors of quality of life encompass general 
fatigue, relationship distress, nuclear family, and time since diagnosis [31].
According to the literature, malocclusion has an impact on OHRQoL. It has been proven that with 
the increased severity of the malocclusion and with more severely compromised esthetics, patients 
experience lower OHRQoL [15,32]. Moreover, among different types of malocclusion, the most 
significant impacts on OHRQoL were caused by impacted canine, increased overjet, and displacement 
of teeth [32]. Not only the type of malocclusion but also the orthodontic treatment by itself has an 
impact on OHRQoL. Demirovic et al. [33] found that patients who had completed the orthodontic 
treatment had better OHRQoL than those who had never undergone orthodontic treatment. Moreover, 
adults who required both orthodontic treatment and orthognathic surgery achieved the biggest 
improvement in OHRQoL, while the least improvement in OHRQoL was observed in patients with 
developmental abnormalities, including cleft lip, cleft palate, or a combination of both [34]. Nascimento 
et al. [35] concluded that orthodontic treatment provided psychological benefits, because it led to a 
significant increase in self-esteem and improvement in the quality of life. Our results also supported 
these observations. Patients from both groups presented significant improvement of the values of 
oral-health-related quality of life at the end of orthodontic treatment comparing to the values achieved 
before the onset of orthodontic treatment. Although, the participants treated orthodontically with 
the rapid protocol achieved slightly better results regarding the OHIP-14 mean total score at the 
end of orthodontic treatment, there were no significant differences between the examined groups. 
These results indicate that the duration of orthodontic treatment does not have a significant impact on 
the oral-health-related quality of life in cancer survivors.
Besides the above-mentioned observations, we have also found that oral-health-related quality of 
life significantly decreased after two weeks and three months after the onset of orthodontic treatment. 
The OHIP-14 mean total score values were significantly higher two weeks and three months after the 
onset of orthodontic treatment comparing to the values obtained before the orthodontic treatment. 
This was mostly the result of increased physical pain within the first three months of orthodontic 
treatment. Moreover, the OHIP-14 mean total score values achieved three months after the onset of the 
orthodontic treatment were significantly lower comparing to the values obtained two weeks after the 
onset of the orthodontic treatment. These results indicate that although oral-health-related quality of 
life significantly decreased after bonding the fixed appliances, it also improved after a few months 
of orthodontic treatment, which may be explained that the patients got used to the inconvenience 
related to orthodontic therapy. Similar results presenting significant decrease of oral-health-related 
quality of life within the first three months of orthodontic treatment were also obtained by Johal et 
al. [17]. However, the authors did not find any significant differences in oral-health-related quality of 
life between before and after the end of orthodontic treatment.
There are several limitations to our study. First of all, there was a limited number of participants 
included into the study. The rapid group consisted of 36 cancer survivors, whereas the standard 
group consisted of 40 cancer survivors. Secondly, the median age was under 20 years old. Therefore, 
the obtained results should not be generalized for the elderly population of cancer survivors. Thirdly, 
cancer survivors were not allocated into the groups at random but on the basis of the result of specialist 
oncological consultation. Patients, who were allocated into the rapid orthodontic group, were at risk 
of possible hospitalization, magnetic resonance imaging examination, or any other types of oncological 
examinations that could have influenced orthodontic treatment within the following one year. It may 
be speculated that although cancer survivors from the rapid group finished their orthodontic treatment 
earlier than the standard group, they could have been full of fears regarding the above-mentioned 
hospitalization or additional examinations, which could have had a direct impact on their general 
quality of life. Fourthly, although we did our best to perfectly match the groups regarding the type of 
malocclusion, there were some insignificant differences between the groups. Moreover, it should be 
clearly stated that even if different types of malocclusion seem to be very similar, they are never the 
same ones. One of the most important aspects, that influences the course of orthodontic treatment is 
the biological response to the orthodontic mechanics.
5. Conclusions
The results of the orthodontic treatment obtained in both groups were similar, although one of the 
groups had received shorter orthodontic treatment. Duration of orthodontic treatment did not influence 
the oral-health-related quality of life in cancer survivor patients. Orthodontic treatment had a positive 
impact on oral-health-related quality of life in both groups of cancer survivors. However, within first 
three months after the onset of orthodontic treatment, significant worsening of oral-health-related 
quality of life was observed. Rapid orthodontic treatment can be completed successfully in cancer 
survivors without any negative impact on oral-health-related quality of life or on the general outcome 
of the treatment.
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